Akademska digitalna zbirka SLovenije - logo
E-viri
Celotno besedilo
Recenzirano Odprti dostop
  • Parkinson's Disease Motor S...
    Santos García, Diego; Canfield, Hector; de Deus Fonticoba, Teresa; Cores Bartolomé, Carlos; Naya Ríos, Lucía; García Roca, Lucía; Martínez Miró, Cristina; Jesús, Silvia; Aguilar, Miquel; Pastor, Pau; Cosgaya, Marina; García Caldentey, Juan; Caballol, Nuria; Legarda, Inés; Hernández Vara, Jorge; Cabo, Iria; López Manzanares, Lydia; González Aramburu, Isabel; Ávila Rivera, María A; Gómez Mayordomo, Víctor; Nogueira, Víctor; Puente, Víctor; Dotor, Julio; Borrué, Carmen; Solano Vila, Berta; Álvarez Sauco, María; Vela, Lydia; Escalante, Sonia; Cubo, Esther; Carrillo Padilla, Francisco; Martínez Castrillo, Juan C; Sánchez Alonso, Pilar; Alonso Losada, Maria G; López Ariztegui, Nuria; Gastón, Itziar; Kulisevsky, Jaime; Blázquez Estrada, Marta; Seijo, Manuel; Rúiz Martínez, Javier; Valero, Caridad; Kurtis, Mónica; de Fábregues, Oriol; González Ardura, Jessica; Alonso Redondo, Ruben; Ordás, Carlos; López Díaz, Luis M; McAfee, Darrian; Martinez-Martin, Pablo; Mir, Pablo

    Journal of Parkinson's disease, 01/2022, Letnik: 12, Številka: 3
    Journal Article

    Motor phenotype (MP) can be associated with a different prognosis in Parkinson's disease (PD), but it is not fixed and can change over time. Our aim was to analyze how the MP changed over time and to identify factors associated with the changes in PD patients from a multicenter Spanish PD cohort. PD patients who were recruited from January-2016 to November-2017 (baseline visit; V0) and evaluated again at a 2-year±30 days follow-up (V2) from 35 centers of Spain from the COPPADIS cohort, were included in this study.MP was calculated at both visits based on Jankovic classification in TD (tremor dominant), IND (indeterminate), or PIGD (postural instability and gait difficulty). Sociodemographic and clinical data were collected, including serum biomarkers. Five hundred eleven patients (62.57±8.59 years old; 59.2%males) were included in the study. At V0, MP was: 47.4%(242/511) TD; 36.6%(187/511) PIGD; 16%(82/511) IND. Up to 38%(194/511) of the patients changed their phenotype from V0 to V2, being the most frequent from TD to IND (8.4%) and from TD to PIGD (6.7%). A worse cognitive status (OR = 0.966) and less autonomy for activities of daily living (OR  =  0.937) at V0 and a greater increase in the globalNMS burden (OR  =  1.011) from V0 to V2 were associated with changing from TD to another phenotype after 2-year follow-up. The MP in PD can change over time. With disease progression, the percentage of cases with non-tremoric MP increases. PD patients who changed from TD to postural instability and gait difficulty increased NMS burden significantly.